Literature DB >> 32140479

Expanding treatment strategies for hepatocellular carcinoma patients: postoperative adjuvant transarterial chemoembolization.

Rodolfo Sacco1, Antonio Facciorusso1.   

Abstract

Entities:  

Year:  2020        PMID： 32140479      PMCID： PMC7026796          DOI： 10.21037/hbsn.2019.11.33

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  14 in total

1.  Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.

Authors:  Davide Citterio; Antonio Facciorusso; Carlo Sposito; Roberta Rota; Sherrie Bhoori; Vincenzo Mazzaferro
Journal:  JAMA Surg       Date:  2016-09-01       Impact factor: 14.766

2.  Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study.

Authors:  Zheng Wang; Zhenggang Ren; Yi Chen; Jie Hu; Guohuan Yang; Lei Yu; Xinrong Yang; Ao Huang; Xin Zhang; Shaolai Zhou; Huichuan Sun; Yanhong Wang; Ningling Ge; Xiaoyu Xu; Zhaoyou Tang; Wanyee Lau; Jia Fan; Jiping Wang; Jian Zhou
Journal:  Clin Cancer Res       Date:  2018-02-02       Impact factor: 12.531

Review 3.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

4.  Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.

Authors:  Yao-Chun Hsu; Hsiu J Ho; Ming-Shiang Wu; Jaw-Town Lin; Chun-Ying Wu
Journal:  Hepatology       Date:  2013-05-15       Impact factor: 17.425

5.  Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  Bao-Gang Peng; Qiang He; Jia-Ping Li; Fan Zhou
Journal:  Am J Surg       Date:  2009-03-12       Impact factor: 2.565

6.  Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.

Authors:  Jordi Bruix; Tadatoshi Takayama; Vincenzo Mazzaferro; Gar-Yang Chau; Jiamei Yang; Masatoshi Kudo; Jianqiang Cai; Ronnie T Poon; Kwang-Hyub Han; Won Young Tak; Han Chu Lee; Tianqiang Song; Sasan Roayaie; Luigi Bolondi; Kwan Sik Lee; Masatoshi Makuuchi; Fabricio Souza; Marie-Aude Le Berre; Gerold Meinhardt; Josep M Llovet
Journal:  Lancet Oncol       Date:  2015-09-08       Impact factor: 41.316

7.  Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.

Authors:  Matthias Pinter; Arndt Weinmann; Marcus-Alexander Wörns; Florian Hucke; Simona Bota; Jens U Marquardt; Dan G Duda; Rakesh K Jain; Peter R Galle; Michael Trauner; Markus Peck-Radosavljevic; Wolfgang Sieghart
Journal:  United European Gastroenterol J       Date:  2017-02-26       Impact factor: 4.623

8.  Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.

Authors:  Han Wang; Peng-Cheng Du; Meng-Chao Wu; Wen-Ming Cong
Journal:  Hepatobiliary Surg Nutr       Date:  2018-12       Impact factor: 7.293

Review 9.  Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.

Authors:  Clifford Akateh; Sylvester M Black; Lanla Conteh; Eric D Miller; Anne Noonan; Eric Elliott; Timothy M Pawlik; Allan Tsung; Jordan M Cloyd
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

10.  Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.

Authors:  Jia-Zhou Ye; Jun-Ze Chen; Zi-Hui Li; Tao Bai; Jie Chen; Shao-Liang Zhu; Le-Qun Li; Fei-Xiang Wu
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.